Relapsing-remitting multiple sclerosis and Retinal oedema

Summary:

Retinal oedema is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Retinal oedema with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 24 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Retinal oedema?

Retinal oedema (swelling of retina) is found to be associated with 126 drugs and 298 conditions by eHealthMe. Check the latest studies of Retinal oedema.



On Aug, 02, 2026

24 people who have Relapsing-Remitting Multiple Sclerosis and Retinal Oedema are studied.

Would you have Retinal oedema when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Retinal Oedema *:

  • female: 91.3 %
  • male: 8.7 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Retinal Oedema *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.5600000000000005 %
  • 30-39: 0.0 %
  • 40-49: 22.22 %
  • 50-59: 50.0 %
  • 60+: 22.22 %

Common co-existing conditions for these people *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.33%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 4.17%

Common drugs taken by these people *:

  1. Gilenya: 23 people, 95.83%
  2. Wellbutrin: 3 people, 12.50%
  3. Seroquel: 3 people, 12.50%
  4. Atropine: 3 people, 12.50%
  5. Celebrex: 3 people, 12.50%
  6. Cymbalta: 3 people, 12.50%
  7. Effexor: 3 people, 12.50%
  8. Lipitor: 3 people, 12.50%
  9. Prednisolone: 3 people, 12.50%
  10. Ritalin: 3 people, 12.50%

Common symptoms for these people *:

  1. Vision Blurred: 11 people, 45.83%
  2. Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 11 people, 45.83%
  3. Visual Impairment: 6 people, 25.00%
  4. Visual Acuity Reduced (reduced clearness of vision): 6 people, 25.00%
  5. Uveitis (inflammation of the uvea): 6 people, 25.00%
  6. Macular Scar: 4 people, 16.67%
  7. White Blood Cell Count Decreased: 3 people, 12.50%
  8. Eye Infection Toxoplasmal (a germ called toxoplasma can cause infection within the eye): 3 people, 12.50%
  9. Mean Cell Haemoglobin Concentration Decreased (less concentration of haemoglobin in a given volume of packed red blood cells): 3 people, 12.50%
  10. Vitritis (inflammation of the vitreous humour of the eye): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Retinal oedema?

- Check whether Retinal oedema is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Retinal oedema:

All the conditions that are associated with Retinal oedema:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Retinal oedema and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: